Current Edition

Current Features

Advertisement

Current Edition

Upcoming Events

Advertisement

Volume 7 Issue 3

Bridging the Care Gap for Children with Medical Complexity

Children with medical complexity (CMC) live with congenital or acquired multi-system diseases, severe neurologic conditions with marked functional impairment, and/or...
Continue Reading →
Volume 7 Issue 3

Breaking Down Barriers for Postgraduate Researchers

How truly open access publishing models improve project outcomes for postgraduate research students One of the hardest things about starting a research project is...
Continue Reading →
Current Features

Leveraging Simplicity to Enhance Efficiency for First-in-human Clinical Trials

It is well-known that going from drug discovery to commercialisation takes, on average, 10–15 years and poses significant costs – approximately $2.6 billion when R&a...
Continue Reading →
Volume 7 Issue 3

CellShip: An Ambient Temperature Transport and Short-term Storage Medium for Mammalian Cell Cultures

Cell culture is fundamental to many research and industrial processes, but traditional transport methods are fraught with challenges. Cryopreservation, the most comm...
Continue Reading →
Volume 7 Issue 3

AI in Drug Discovery: High-throughput SPR Boosts Breakthroughs

Artificial intelligence (AI) is revolutionising drug discovery, enabling scientists to identify novel therapeutic candidates in a fraction of the time it once requir...
Continue Reading →
Volume 7 Issue 3

Small Molecule Microarrays: An established Hit-identification Technique with New Potential for Challenging Targets.

Small molecule microarray (SMM) is a well-established method for identifying small molecule (SM) binding interactions with a diverse range of target types. It has pr...
Continue Reading →
Volume 7 Issue 3

Enhancing Therapeutic Antibody Development via Synthetic Phage Display Technology

Phage display technology has played a key role in the discovery and optimisation of antibodies for a wide range of clinical or research applications, with its greate...
Continue Reading →
Volume 7 Issue 3

Understanding the Corporate Sustainability Reporting Directive in Europe and Its Implications for Medium-sized Companies

The issue of sustainability has garnered increasing attention across the globe, with particular emphasis on small and medium-sized enterprises (SME). These companies...
Continue Reading →
Volume 7 Issue 3

Considerations on In Vitro Disease Models with Focus on Fibrosis

The evolution of disease modelling has seen a paradigm shift from the traditional use of animal models to more advanced in vitro human-based systems. This has been d...
Continue Reading →

Company Profiles